C12N 2770/36251
Methods of production or purification of viral material
C12N2770/36251 (Methods of production or purification of viral material) appears on 8 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 6
- Assignees
- 9
- Inventors
- 21
- Latest grant
- 10 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Rubella virus spike construct10 Oct 2023US 11,780,884 B2Institut Virion \ Serion GmbH
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- Methods and devices for quantitative viral assays8 Dec 2015US 9,206,396 B2Wisconsin Alumni Research Foundation
- Polyvalent chimeric rubella virus-based vaccines11 Jun 2013US 8,460,680 B2National Health Research Institutes
- Stabilizers for live vaccines15 May 2001US 6,231,860 B1Pasteur Merieux Serums & Vaccins
- Rubella virus spike construct26 Aug 2021US 2021/0261624 A1Institut Virion \ Serion GmbH
- Methods and compositions related to increased viral production9 Jan 2020US 2020/0010830 A1University of Georgia Research Foundation, Inc.
- Polyvalent chimeric rubella virus-based vaccines28 Oct 2010US 2010/0272747 A1National Health Research Institutes
- Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process4 Dec 2008US 2008/0299150 A1Sankhia Corporation
- Methods and Devices for Quantitative Viral Assays17 May 2007US 2007/0111296 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents
- Production of viruses in tissue culture without use of serum39US 4,072,565 AThe Dow Chemical Company · 1978
- Stabilizers for live vaccines25US 6,231,860 B1Pasteur Merieux Serums & Vaccins · 2001
- Polyvalent chimeric rubella virus-based vaccines4US 8,460,680 B2National Health Research Institutes · 2013
- Highly infectious rubella virus clones and methods of production1US 6,054,573 AGeorgia State University · 2000